These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9801703)

  • 21. Troglitazone's effect on lipoprotein(a) levels.
    Ovalle F; Bell DS
    Diabetes Care; 1999 May; 22(5):859-60. PubMed ID: 10332700
    [No Abstract]   [Full Text] [Related]  

  • 22. Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.
    Yao L; Mizushige K; Noma T; Murakami K; Ohmori K; Matsuo H
    Heart; 2000 Aug; 84(2):209. PubMed ID: 10908265
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase of lipoprotein (a) with troglitazone.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Tominaga Y
    Lancet; 1997 Dec; 350(9093):1748-9. PubMed ID: 9413470
    [No Abstract]   [Full Text] [Related]  

  • 24. New directions in treating insulin resistance.
    Reusch JE
    Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
    [No Abstract]   [Full Text] [Related]  

  • 25. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
    Westerbacka J; Yki-Järvinen H
    Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
    [No Abstract]   [Full Text] [Related]  

  • 26. New therapeutic approaches to reversing insulin resistance.
    Sonnenberg GE; Kotchen TA
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac hypertrophy in diabetes patients with and without hypertension: effects of troglitazone, a novel antidiabetic drug, on diastolic function.
    Makino N; Hirayama H; Yonemochi H; Yano K; Abe N
    Adv Exp Med Biol; 2001; 498():143-8. PubMed ID: 11900362
    [No Abstract]   [Full Text] [Related]  

  • 28. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
    Teter ML
    Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
    [No Abstract]   [Full Text] [Related]  

  • 29. Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect.
    Sakurai A; Hashizume K
    Arch Intern Med; 2000 Jan; 160(1):118-9. PubMed ID: 10632316
    [No Abstract]   [Full Text] [Related]  

  • 30. The glitazones: proceed with caution.
    Krische D
    West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299
    [No Abstract]   [Full Text] [Related]  

  • 31. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
    Fujibayashi K; Nagasaka S; Itabashi N; Kawakami A; Nakamura T; Kusaka I; Ishikawa S; Saito T
    Diabetes Care; 1999 Dec; 22(12):2088-9. PubMed ID: 10587851
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible troglitazone-warfarin interaction.
    Plowman BK; Morreale AP
    Am J Health Syst Pharm; 1998 May; 55(10):1071. PubMed ID: 9606460
    [No Abstract]   [Full Text] [Related]  

  • 33. How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy SS
    Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
    [No Abstract]   [Full Text] [Related]  

  • 34. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
    Samraj GP; Kuritzky L; Quillen DM
    Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
    [No Abstract]   [Full Text] [Related]  

  • 35. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 37. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of troglitazone.
    Umland EM; Romanelli AM
    Ann Pharmacother; 1999 Feb; 33(2):229-32. PubMed ID: 10084419
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost of Troglitazone therapy.
    Bachman KH
    Arch Intern Med; 1998 May; 158(9):1038. PubMed ID: 9616110
    [No Abstract]   [Full Text] [Related]  

  • 40. Troglitazone interferes with gemfibrozil's lipid-lowering action.
    Bell DS; Ovalle F
    Diabetes Care; 1998 Nov; 21(11):2028-9. PubMed ID: 9802763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.